Our findings that T cells activated by DCs fused with tumor-derived endothelial cells could induce higher levels of IFN-α and IFN-γ, as well as significantly reinforce CTL responses in vitro or in vivo, which may help in designing optimal strategies for the therapy and may improve DC/EC fusion-based vaccination strategies. Here, IFNG is linked to neoplasm.